• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能涉及溶血磷脂酸受体-5 基因在大鼠肿瘤细胞获得生长优势中的作用。

Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells.

机构信息

Division of Cancer Biology and Bioinformatics, Department of Life Science, Kinki University, Higashiosaka, Osaka, Japan.

出版信息

Mol Carcinog. 2011 Aug;50(8):635-42. doi: 10.1002/mc.20750. Epub 2011 Mar 3.

DOI:10.1002/mc.20750
PMID:21374735
Abstract

Aberrant expressions of lysophosphatidic acid (LPA) receptor genes have been reported in tumor cells. Here, we measured the expression levels of the Lpa5 gene and its DNA methylation status in rat tumor cells, and investigated cell growth effects of LPA in Lpa5 expressed cells. Real-time reverse transcription (RT)-polymerase chain reaction (PCR) analysis revealed that increased expressions of the Lpa5 gene were detected in rat liver-derived hepatoma RH7777 and lung-derived adenocarcinoma RLCNR cells. For the analysis of methylation status, bisulfite sequencing was performed with RH7777 and RLCNR cells and compared with other tumor cells and liver epithelial cells. The Lpa5 gene in Lpa5 unexpressed cells and liver epithelial cells were highly methylated in the 5' upstream region. In contrast, the Lpa5 gene in RH7777 and RLCNR cells was unmethylated, correlating with increased expressions of Lpa5. In the assays for cell growth effects of LPA, LPA enhanced cell proliferation and motility in RH7777 and RLCNR cells. LPA also stimulated cell invasion in RLCNR, but not in RH7777 cells. In rat liver and lung tumors induced by nitroso-compounds, 4 out of 6 hepatocellular carcinomas and 5 out of 6 lung adenocarcinomas indicated increased expressions of Lpa5 with unmethylated status. These results suggest that increased Lpa5 expressions due to aberrant DNA methylation may be involved in the acquisition of growth advantage of rat tumor cells.

摘要

溶血磷脂酸 (LPA) 受体基因的异常表达已在肿瘤细胞中报道。在这里,我们测量了大鼠肿瘤细胞中 Lpa5 基因的表达水平及其 DNA 甲基化状态,并研究了 LPA 在 Lpa5 表达细胞中的细胞生长效应。实时逆转录(RT)-聚合酶链反应(PCR)分析显示,在大鼠肝源性肝癌 RH7777 和肺源性腺癌 RLCNR 细胞中检测到 Lpa5 基因的表达增加。为了分析甲基化状态,对 RH7777 和 RLCNR 细胞进行了亚硫酸氢盐测序,并与其他肿瘤细胞和肝上皮细胞进行了比较。Lpa5 未表达细胞和肝上皮细胞中的 Lpa5 基因在 5'上游区域高度甲基化。相比之下,RH7777 和 RLCNR 细胞中的 Lpa5 基因未甲基化,与 Lpa5 的表达增加相关。在 LPA 对细胞生长效应的测定中,LPA 增强了 RH7777 和 RLCNR 细胞的增殖和迁移。LPA 还刺激 RLCNR 中的细胞侵袭,但不刺激 RH7777 细胞。在亚硝化合物诱导的大鼠肝和肺癌肿瘤中,6 个肝细胞癌中有 4 个和 6 个肺腺癌中有 5 个显示 Lpa5 表达增加,且甲基化状态未甲基化。这些结果表明,由于异常 DNA 甲基化导致的 Lpa5 表达增加可能参与了大鼠肿瘤细胞获得生长优势。

相似文献

1
Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells.可能涉及溶血磷脂酸受体-5 基因在大鼠肿瘤细胞获得生长优势中的作用。
Mol Carcinog. 2011 Aug;50(8):635-42. doi: 10.1002/mc.20750. Epub 2011 Mar 3.
2
Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells.缺失溶血磷脂酸受体-3 可增强大鼠肺肿瘤细胞的迁移。
Biochem Biophys Res Commun. 2011 Feb 18;405(3):450-4. doi: 10.1016/j.bbrc.2011.01.051. Epub 2011 Jan 19.
3
Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines.异常DNA甲基化与大鼠肿瘤细胞系中溶血磷脂酸受体-1基因表达降低的关系。
Biochem Biophys Res Commun. 2006 Oct 27;349(3):1151-5. doi: 10.1016/j.bbrc.2006.08.159. Epub 2006 Sep 5.
4
Distinct DNA methylation patterns of lysophosphatidic acid receptor genes during rat hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet.胆碱缺乏 L-氨基酸定义饮食诱导大鼠肝癌发生过程中溶血磷脂酸受体基因的独特 DNA 甲基化模式。
Arch Toxicol. 2011 Oct;85(10):1303-10. doi: 10.1007/s00204-011-0656-7. Epub 2011 Feb 3.
5
Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells.溶血磷脂酸受体 3 增强大鼠肝癌 RH7777 细胞的致瘤性和侵袭性。
Mol Carcinog. 2013 Apr;52(4):247-54. doi: 10.1002/mc.21851. Epub 2011 Dec 7.
6
Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA in melanoma cells treated with anticancer drugs.通过在接受抗癌药物治疗的黑素瘤细胞中 LPA 信号对溶脂性磷脂酸(LPA)的化学耐药性进行调节。
Biochem Biophys Res Commun. 2019 Sep 17;517(2):359-363. doi: 10.1016/j.bbrc.2019.07.092. Epub 2019 Jul 27.
7
Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells.12-O-十四烷酰佛波醇-13-乙酸酯诱导溶血磷脂酸受体-3 的表达可刺激大鼠肝细胞的迁移。
Cancer Lett. 2011 Oct 28;309(2):236-42. doi: 10.1016/j.canlet.2011.06.020. Epub 2011 Jun 24.
8
Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells.人结肠癌细胞中溶血磷脂酸受体基因的差异表达和 DNA 甲基化模式。
Virchows Arch. 2010 Dec;457(6):669-76. doi: 10.1007/s00428-010-0960-2. Epub 2010 Oct 3.
9
Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.溶血磷脂酸受体-5对肉瘤细胞细胞功能的抑制作用。
Growth Factors. 2014 Jun;32(3-4):117-22. doi: 10.3109/08977194.2014.911294. Epub 2014 May 6.
10
Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na/H exchanger 3 by lysophosphatidic acid in vivo.体内溶血磷脂酸通过激活溶血磷脂酸受体 5 调节肠道 Na/H 交换蛋白 3 的表达。
Am J Physiol Gastrointest Liver Physiol. 2018 Oct 1;315(4):G433-G442. doi: 10.1152/ajpgi.00130.2018. Epub 2018 May 24.

引用本文的文献

1
Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments.揭示治疗潜力:探索恶性骨肿瘤中的溶血磷脂酸 (LPA) 信号转导,以寻求新型癌症治疗方法。
Lipids Health Dis. 2024 Jun 28;23(1):204. doi: 10.1186/s12944-024-02196-9.
2
Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology.溶血磷脂酸(LPA)受体介导的信号通路在癌细胞生物学中的作用。
J Bioenerg Biomembr. 2024 Aug;56(4):475-482. doi: 10.1007/s10863-024-10028-9. Epub 2024 Jun 18.
3
LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway.
LPAR5 通过 ERK/Snail 通路赋予 EMT 激活相关的癌细胞放射抗性。
J Transl Med. 2022 Oct 5;20(1):456. doi: 10.1186/s12967-022-03673-4.
4
gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.胃肠道癌症中的基因与自分泌运动因子-溶血磷脂酸轴
World J Gastrointest Oncol. 2022 Aug 15;14(8):1388-1405. doi: 10.4251/wjgo.v14.i8.1388.
5
Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?溶血磷脂酸信号在癌细胞中的作用:是什么让 LPA 如此特别?
Cells. 2021 Aug 11;10(8):2059. doi: 10.3390/cells10082059.
6
Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials.溶血磷脂酸受体拮抗剂与癌症:当前趋势、临床意义和试验。
Cells. 2021 Jun 29;10(7):1629. doi: 10.3390/cells10071629.
7
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.溶血磷脂酸及其受体在健康和疾病中的作用:新的治疗策略。
Signal Transduct Target Ther. 2021 Feb 1;6(1):45. doi: 10.1038/s41392-020-00367-5.
8
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.靶向癌症中的溶血磷脂酸:从实验室到临床面临的问题。
Cancers (Basel). 2019 Oct 10;11(10):1523. doi: 10.3390/cancers11101523.
9
Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer.溶血磷脂酸及自分泌运动因子对结直肠癌发生发展的相关影响。
Cancers (Basel). 2019 Jul 9;11(7):958. doi: 10.3390/cancers11070958.
10
Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.自分泌运动因子-溶血磷脂酸受体轴对肿瘤细胞-微环境相互作用的调控
Adv Biol Regul. 2019 Jan;71:183-193. doi: 10.1016/j.jbior.2018.09.008. Epub 2018 Sep 16.